["Immune type" haemolysis in course of L. dopa-benserazide therapeutic (author's transl)].
作者信息
Conte P, Moulinier J, Reiffers J, Julien J
出版信息
Nouv Presse Med. 1979 Jan 6;8(1):46-7.
PMID:554063
Abstract
摘要
相似文献
1
["Immune type" haemolysis in course of L. dopa-benserazide therapeutic (author's transl)].左旋多巴-苄丝肼治疗过程中的“免疫型”溶血（作者译）
Nouv Presse Med. 1979 Jan 6;8(1):46-7.
2
Acute non-haemolytic anemia after short administration of L Dopa plus Benserazide.短期服用左旋多巴加苄丝肼后出现急性非溶血性贫血。
Ann Allergy. 1982 Jun;48(6):362.
3
[Outcome of Parkinsonism after two years of levodopa plus R04-4602 (author's transl)].左旋多巴加R04 - 4602治疗两年后帕金森症的结局（作者译）
Riv Patol Nerv Ment. 1975 Jul-Aug;96(4):270-86.
4
[Madopar in the treatment of paralysis agitans. I. Therapeutic efficacy and side-effects in 56 cases (author's transl)].美多芭治疗震颤麻痹。I. 56例的治疗效果与副作用（作者译）
Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1980;13(3):147-50.
5
[The association of L-DOPA and Ro 4-4602 in the treatment of Parkinson's disease (author's transl)].左旋多巴与Ro 4-4602联合治疗帕金森病（作者译）
Riv Patol Nerv Ment. 1974 Oct;95(5):673-5.
6
[Psychological changes in parkinsonian patients during L-DOPA, amantidine, and L-DOPA + IDC treatment (author's transl)].帕金森病患者在左旋多巴、金刚烷胺及左旋多巴+IDC治疗期间的心理变化（作者译）
Riv Patol Nerv Ment. 1974 Oct;95(5):676-84.
7
[Long-term syndrome in the treatment of parkinsonism with L-dopa and decarboxylase an inhibitor].[左旋多巴与脱羧酶抑制剂治疗帕金森病的长期综合征]
Neurol Neurocir Psiquiatr. 1976;17(4):255-68.
8
[Levodopa and decarboxylase inhibitors in Parkinson's disease].[左旋多巴与脱羧酶抑制剂治疗帕金森病]
Lakartidningen. 1977 Jan 5;74(1-2):37-40.
9
10
Parkinson's disease in the elderly: a long-term efficacy study of levodopa/benserazide combination therapy.老年帕金森病：左旋多巴/苄丝肼联合治疗的长期疗效研究
Pharmatherapeutica. 1986;4(9):571-6.
Zotero 插件